Clinical Trial Update: Real-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China

View source ↗

Summary

This clinical trial update describes a real-world evaluation of trastuzumab deruxtecan in Chinese patients with HER2-positive gastric or gastroesophageal juncti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Trastuzumab deruxtecan (trastuzumab deruxtecan)

Snippet

Sponsor: Daiichi Sankyo | Conditions: HER2-positive Gastric Cancer, HER2-positive Gastroesophageal Junction | Status: RECRUITING